{
  "id": "cardiac_action_potential_physiology_001",
  "updatedAt": "2026-02-18T00:00:00Z",

  "domain": "physiology",
  "topicTagIds": ["cardiovascular_physiology", "cardiac_electrophysiology", "action_potential"],
  "caseId": null,
  "slotType": "any",
  "caseOrder": 0,

  "demographics": {
    "patientAgeGroup": "adult",
    "patientGender": "female"
  },

  "stem": "Dr. {{candidate_name}}, can you describe the cardiac action potential?",

  "prompts": [
    {
      "tier": "recall",
      "text": "Describe the phases of the ventricular myocyte action potential.",
      "expectedKeyFacts": [
        "Phase 0: Rapid depolarisation — voltage-gated sodium channels open",
        "Phase 1: Early repolarisation — sodium channels close, potassium efflux begins",
        "Phase 2: Plateau — calcium influx balances potassium efflux",
        "Phase 3: Repolarisation — calcium channels close, potassium efflux continues",
        "Phase 4: Resting potential — maintained by Na+/K+-ATPase",
        "Resting potential ~-90 mV, peak +20 mV",
        "Duration ~250-300 ms"
      ],
      "timeBudgetSec": 60
    },
    {
      "tier": "mechanism",
      "text": "What is the significance of the plateau phase in cardiac muscle?",
      "expectedKeyFacts": [
        "Prolonged depolarisation due to L-type calcium channels",
        "Calcium influx triggers calcium-induced calcium release from sarcoplasmic reticulum",
        "Enables sustained contraction — unlike skeletal muscle",
        "Long refractory period prevents tetanic contraction",
        "Ensures adequate ventricular filling between beats",
        "Vulnerable period during phase 3 — risk of arrhythmias if stimulated"
      ],
      "timeBudgetSec": 90
    },
    {
      "tier": "application",
      "text": "How does the pacemaker cell action potential differ from ventricular myocytes?",
      "expectedKeyFacts": [
        "No true resting potential — spontaneous depolarisation (phase 4)",
        "Pacemaker potential: slow depolarisation due to 'funny current' (If) — sodium influx",
        "Also calcium leak channels contribute",
        "Maximum diastolic potential ~-60 mV (less negative than ventricle)",
        "Phase 0: calcium influx (not sodium) — slower upstroke",
        "No plateau phase",
        "Autonomic modulation: sympathetic increases If, parasympathetic (vagal) increases potassium efflux"
      ],
      "timeBudgetSec": 90
    },
    {
      "tier": "synthesis",
      "text": "How do class III antiarrhythmic drugs work and what are the risks?",
      "expectedKeyFacts": [
        "Block potassium channels — prolong phase 3 repolarisation",
        "Increase action potential duration and refractory period",
        "Examples: amiodarone, sotalol",
        "Prevent re-entry arrhythmias by prolonging refractoriness",
        "Risk: excessive QT prolongation",
        "Torsades de pointes — polymorphic VT",
        "Triggered activity during early after-depolarisations",
        "Worse with hypokalaemia, hypomagnesaemia, bradycardia"
      ],
      "timeBudgetSec": 90
    },
    {
      "tier": "evaluation",
      "text": "Why does the heart have a long refractory period compared to skeletal muscle?",
      "expectedKeyFacts": [
        "Absolute refractory period ~250 ms — coincides with mechanical systole",
        "Prevents tetanic contraction which would be fatal",
        "Ensures adequate diastolic filling time",
        "Allows coordinated sequential contraction",
        "Skeletal muscle short refractory period allows tetanus for sustained force",
        "Heart requires rhythmic relaxation for circulatory function",
        "Relative refractory period allows premature beats but with reduced force"
      ],
      "timeBudgetSec": 60
    }
  ],

  "rescuePrompt": "Perhaps you could tell me about the role of calcium in the cardiac action potential — when does it enter the cell and what does it do?",

  "keyFacts": [
    "Phase 0: rapid depolarisation (Na+ influx)",
    "Phase 1: early repolarisation (K+ efflux)",
    "Phase 2: plateau (Ca²+ influx balances K+ efflux)",
    "Phase 3: repolarisation (K+ efflux)",
    "Phase 4: resting potential (-90 mV)",
    "Pacemaker cells: spontaneous depolarisation, funny current (If)",
    "Long refractory period prevents tetany",
    "Calcium triggers contraction via CICR",
    "Class III drugs block K+ channels — prolong AP",
    "Torsades de pointes risk with QT prolongation"
  ],

  "scoringGuidance": {
    "pass": "Correctly describes 5 phases with ion movements, explains plateau phase and calcium's role, distinguishes pacemaker from ventricular AP, understands refractory period significance, knows class III drug mechanism; stronger candidates explain funny current and triggered activity",
    "borderline": "Knows phases exist but unclear on ion movements, mentions calcium but vague on significance, confused about pacemaker vs ventricular cells",
    "fail": "Cannot describe phases, does not understand ion channels or currents, unaware of plateau significance or refractory period, no knowledge of pacemaker physiology"
  },

  "author": "SimViva Team",
  "provenance": {
    "generatedBy": "Claude (Anthropic)",
    "generatedAt": "2026-02-18T21:10:00Z",
    "promptVersion": "v1.0.0",
    "sourceMaterial": ["Cardiovascular_Physiology_Textbook_2019", "BJA_Cardiac_Electrophysiology_2020"],
    "validation": {
      "reviewedBy": "",
      "reviewedAt": "",
      "status": "pending_review",
      "notes": "Awaiting clinical reviewer sign-off."
    }
  },
  "furtherReading": [
    "https://doi.org/10.1093/bjaceaccp/mkt015"
  ],
  "isActive": true
}
